Evidence map›Paper›PMID 37987600›Full record

ArticleEmerging infectious diseases2023

OXA-48-Producing Uropathogenic Escherichia coli Sequence Type 127, the Netherlands, 2015-2022.

Marlies Mulder, Daan W Notermans, Cornelia C H Wielders, Jeroen Bos, Sandra Witteveen, Varisha A Ganesh, Fabian Landman, Angela de Haan, Caroline Schneeberger-van der Linden, Antoni P A Hendrickx and 1 more

Open access · diamondAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Whole-genome characterisation of Escherichia coli isolates from older women with urinary tract infection and asymptomatic bacteriuria.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marlies Mulder
Daan W Notermans
Cornelia C H Wielders
Jeroen Bos
Sandra Witteveen
Varisha A Ganesh
Fabian Landman
Angela de Haan
Caroline Schneeberger-van der Linden
Antoni P A Hendrickx
Dutch CPE Surveillance Study Group1

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During 2015-2022, a genetic cluster of OXA-48-producing uropathogenic Escherichia coli sequence type 127 spread throughout the Netherlands. The 20 isolates we investigated originated mainly from urine, belonged to Clermont phylotype B2, and carried 18 genes encoding putative uropathogenicity factors. The isolates were susceptible to first-choice antimicrobial drugs for urinary tract infections.

Indexed as

Escherichia coli InfectionsUrinary Tract InfectionsUropathogenic Escherichia coliAnti-Bacterial Agentsbeta-LactamasesHumansNetherlandsVirulence FactorsAnti-Bacterial Agentsbeta-LactamasesVirulence Factorsantimicrobial resistancebacteriacarbapenemase-producing EnterobacteralesEscherichia coliOXA-48ST127the NetherlandsUPECuropathogenic Escherichia coli

Identifiers

PMID37987600
PMCPMC10683799
OpenAlexW4388869640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.